||EPS - Basic
||Market Cap (m)
|Health Care Equipment & Services
Omega Diagnostics Share Discussion Threads
Showing 1701 to 1724 of 1725 messages
|Super, for that amount?|
|too emotional there, jeeves. Not a mistake - a rollover or bed+isa or similar.|
|No hint of sarcasm or cynicism there bomber!
Bid rising again ...|
|They are trying to take it down :(. Why would they do that? I am going for my nap.|
|Point taken Dibs61 , and I suspect any fund-raising would be accompanied by a cracking trading update , tiptop news on CD4 , a deal with IDH and directors buying stock for the first time in 3 years ?|
|Interesting and exciting times ahead, any funds required would probably be Debt/Equity, rather than just equity in my opinion, with the equity probably being a private placement to Include Directors as it has been a few years since they bought in the open market.......but we will have to wait and see!!|
|Well as we already know Mr Sneller has sizeable pockets (see my post 1488 on 13 Jan 17).
Interestingly since 13 Jan 17 he has increased his ODX holding by a further 2,733,447 shares and as rivaldo has said 1,133,447 of those since 7 Mar 17 which must have been purchased at 20p or higher.
Looking at his other investments he has since added a few more Bango & Hayward Tyler to his war chest but clearly his obsession with ODX has to bode well for us all 🤓|
|bomber - placing? Wahey bring it on I say. It would be a resounding success. Lots of demand for more shares because they are so illiquid on the open Market. No doubt RS would take his fair share.
I don't think the price would be (significantly) discounted - could even be premium - and the shares would surge subsequently on the realisation they have the capital required to bring Visitect CD4 to market.|
|Good stuff. Sneller has added 1.13m shares in the last 6 weeks. It's a huge personal commitment - 14.19m shares must have cost him at least £2.5m.|
|Sneller has actually been averaging up.|
|I was selling cause i thought there was a placing coming.
Been buying back since yesterday.|
|Dibs, yes I know he has picked up loads in the last several weeks.......but also someone has been offloading as there is limited available in free float..but all bodes well.......|
|......and not expecting a placing ?|
|barry - no not 50k - over 1m shares added since early March taking his stake from 12% to 13%
But as you say it just emphasises this guy has HUGE personal conviction in this stock. And he should know...|
|Good old Richard Sneller another 50k.......he must be very, very confident....|
|Broker said I can' take part in imaginary placing; so, having to buy in open market.
ODX advertising their Malaria RDTs on twitter.|
|Very strong start to trading today. Bucking recent downtrend.|
|Monday it is for the update then.....GLA LTH's|
|IDH says nothing about negotiations with Omega on a broader global distribution arrangement , there again they have never said anything , and their new CEO has only been in the job 7 weeks . I think Omega must wear the trousers in this regard because IDH desperately need Omega's advancing assay portfolio to offset their Vitamin D decline and grow net placements of machines . Pleasing , therefore , to see IDH's net cash up £4.9m to £31.5 m if cash were to change hands . Perhaps , a deal is still being hatched , which might explain the apparent lateness of Omega's trading update ? Next week , let's hope ?|
|Small top-up of 12000 coming...|
|IDH CLIA section had 3% growth in constant exchange rate. Total rose only because of ex-rate impact. ODX helped offer their only truth growth.|
|Very positive update from IDS today::
"Another KPI we are monitoring is the average number of assays run on an iSYS analyzer as a larger number increases our revenues per instrument and increases customer retention. This KPI increased from 3.9 to 4.3 over the year, reflecting the ability of our sales organization for upselling.
We believe the positive progression of the KPIs outlined above reflects the progress made during the course of the year. Our roadmaps for R&D, sales and marketing are clearly outlined and our management team is working on getting better on the respective processes each month. We are therefore optimistic that this progress will continue into the next year."|
|Maybe, there is no equity raise. Instead, we have a commercial agreement with IDS which would undoubtedly bring a re-rate. Just saying :). Find out tomorrow or early next week.|